ClinicalTrials.Veeva

Menu

Nutrition Optimalization Among Pregnant Women to Improve Maternal and Neonatal Outcome in DKI Jakarta (MONAS)

D

Dr Cipto Mangunkusumo General Hospital

Status

Enrolling

Conditions

Neonatal Death
Pregnancy Complications
Preeclampsia
IUGR
Pregnancy Hemorrhage
Maternal Death
Asphyxia Neonatorum
Intrauterine Infection
Low; Birthweight, Extremely (999 Grams or Less)
Preterm Birth

Treatments

Diagnostic Test: Fetomaternal ultrasound
Diagnostic Test: Nutritional panel laboratory examination
Dietary Supplement: Pregnancy supplements (other than provided by Ministry of Health)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this MONAS Study is to learn about comprehensive monitoring and nutritional intervention among pregnant women in order to improve maternal and neonatal outcomes. The main questions it aims to answer are:

  1. Are comprehensive monitoring and nutritional intervention among pregnant women can improve maternal outcomes (maternal death, preterm labour, preeclampsia, intrauterine infection, and bleeding during pregnancy and delivery) compared to standard maternal health services?
  2. Are comprehensive monitoring and nutritional intervention among pregnant women can improve neonatal outcomes (neonatal death, low birth weight, intrauterine growth restriction, and neonatal asphyxia) compared to standard maternal health services?

Participants in the intervention group will receive:

  • Fetomaternal ultrasound examination each trimester
  • Complete laboratory examination for nutritional panel (complete blood count with reticulocyte profile and iron profile, vitamin D level, zinc level, fatty acid profile, electrophoresis for Thalassemia) as an addition to standard maternal routine laboratory examination
  • Supplements: multivitamin, minerals, vitamin D, fatty acid
  • Intervention regarding any abnormal results of nutritional panel
  • All standard maternal health services according to Indonesian Ministry of Health protocol

Participants in the control group will receive:

  • All standard maternal health services according to Indonesian Ministry of Health protocol

Enrollment

245 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnancy in 1st trimester
  • Gestational age less than 10 weeks
  • Living in Jakarta greater area
  • Agree to participate

Exclusion criteria

  • Assisted reproductive technology (IVF)
  • History of polycystic ovary syndrome
  • History of chronic hypertension
  • History of diabetes mellitus
  • History of preeclampsia in the previous pregnancy
  • Had chronic disease: heart disease, autoimmune disease, malignancy, chronic lung disease
  • Planning to have delivery outside Jakarta greater area
  • Poor obstetric history (miscarriage/ abortion more than 3 times)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

245 participants in 2 patient groups

Intervention group
Experimental group
Description:
Participants in the intervention group will receive: * Fetomaternal ultrasound examination each trimester by fetomaternal consultants * Complete laboratory examination for nutritional panel (complete blood count with reticulocyte profile and iron profile, vitamin D level, zinc level, fatty acid profile, electrophoresis for Thalassemia) as an addition to standard maternal routine laboratory examination * Supplements: multivitamin, minerals, vitamin D, fatty acid * Intervention regarding any abnormal results of nutritional panel * All standard maternal health services according to Indonesian Ministry of Health protocol
Treatment:
Dietary Supplement: Pregnancy supplements (other than provided by Ministry of Health)
Diagnostic Test: Nutritional panel laboratory examination
Diagnostic Test: Fetomaternal ultrasound
Control group
No Intervention group
Description:
Participants in the control group will receive: - All standard maternal health services according to Indonesian Ministry of Health protocol

Trial contacts and locations

1

Loading...

Central trial contact

Yurika E Susanti, M.D.; Hardya G Hikmahrachim, M.D., M.Sc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems